Please join Professor Alison Morantz and the Plaintiffs’ Lawyers Association for a discussion with employment law practitioners with plaintiffs’ firms. Panelists will discuss their careers and current events in employment law. Lunch will be served to those who RSVP.
This talk will track the regulatory trajectory of the first therapy approved by the FDA for early Alzheimer’s disease in spite of strong internal and external resistance. This will be attributed in part to FDA’s infrastructure and culture inhibiting the development of a case law tradition that would facilitate institutional learning and consistency.
Please join NLG for lunch and discussion with Alec Karakatsanis about the role of lawyers in the movement to abolish jails and prisons. Alec is the founder and executive director of Civil Rights Corps, a non-profit fighting injustices in the criminal-legal system around the country. CRC has designed and litigated innovative constitutional civil rights cases […]